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BACKGROUND: Atherosclerotic plaques demonstrate extensive 
accumulation of oxidative DNA damage, predominantly as 8-oxoguanine 
(8oxoG) lesions. 8oxoG is repaired by base excision repair enzymes; 
however, the mechanisms regulating 8oxoG accumulation in vascular 
smooth muscle cells (VSMCs) and its effects on their function and in 
atherosclerosis are unknown.
METHODS: We studied levels of 8oxoG and its regulatory enzymes in human 
atherosclerosis, the mechanisms regulating 8oxoG repair and the base excision 
repair enzyme 8oxoG DNA glycosylase I (OGG1) in VSMCs in vitro, and the 
effects of reducing 8oxoG in VSMCs in atherosclerosis in ApoE−/− mice.
RESULTS: Human plaque VSMCs showed defective nuclear 8oxoG repair, 
associated with reduced acetylation of OGG1. OGG1 was a key regulatory 
enzyme of 8oxoG repair in VSMCs, and its acetylation was crucial to its 
repair function through regulation of protein stability and expression. 
p300 and sirtuin 1 were identified as the OGG1 acetyltransferase and 
deacetylase regulators, respectively, and both proteins interacted with 
OGG1 and regulated OGG1 acetylation at endogenous levels. However, 
p300 levels were decreased in human plaque VSMCs and in response 
to oxidative stress, suggesting that reactive oxygen species–induced 
regulation of OGG1 acetylation could be caused by reactive oxygen 
species–induced decrease in p300 expression. We generated mice that 
express VSMC-restricted OGG1 or an acetylation defective version 
(SM22α-OGG1 and SM22α-OGG1K-R mice) and crossed them with ApoE−/− 
mice. We also studied ApoE−/− mice deficient in OGG1 (OGG1−/−). OGG1−/− 
mice showed increased 8oxoG in vivo and increased atherosclerosis, 
whereas mice expressing VSMC-specific OGG1 but not the acetylation 
mutant OGG1K-R showed markedly reduced intracellular 8oxoG and 
reduced atherosclerosis. VSMC OGG1 reduced telomere 8oxoG 
accumulation, DNA strand breaks, cell death and senescence after oxidant 
stress, and activation of proinflammatory pathways.
CONCLUSIONS: We identify defective 8oxoG base excision repair in 
human atherosclerotic plaque VSMCs, OGG1 as a major 8oxoG repair 
enzyme in VSMCs, and p300/sirtuin 1 as major regulators of OGG1 
through acetylation/deacetylation. Reducing oxidative damage by rescuing 
OGG1 activity reduces plaque development, indicating the detrimental 
effects of 8oxoG on VSMC function.
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DNA bases are susceptible to oxidation mediated by reactive oxygen species (ROS). The low redox potential of guanine makes it especially vulner-
able and leads to a plethora of oxidized guanine prod-
ucts.1 8-Oxoguanine (8oxoG) is the most abundant 
DNA lesion formed on oxidative exposure, and the 
presence of 8oxoG is often used as a cellular biomarker 
to indicate the extent of oxidative stress. 8oxoG is a 
highly mutagenic miscoding lesion that can lead to G:C 
to T:A transversion mutations and is widely found in 
human disease and aging.2 However, it is often unclear 
whether 8oxoG accumulation is just a marker of oxida-
tive stress or has a pathogenetic role in disease.
Base excision repair (BER) is the primary mechanism 
for repairing 8oxoG. BER involves the concerted effort 
of several repair proteins that recognize and excise 
oxidized bases, replacing the damaged moiety with a 
normal nucleotide and restoring DNA integrity.3 BER 
is a critical process for genomic maintenance, as high-
lighted by the severe phenotypes of mice deficient in 
BER function, including premature aging and metabolic 
defects.4 However, except for specific BER gene muta-
tions, evidence of defective BER and whether it contrib-
utes to human disease is limited.
Advanced atherosclerotic plaques are characterized 
by 8oxoG accumulation in vascular smooth muscle cells 
(VSMCs), macrophages, and endothelial cells.5,6 8oxoG 
also accumulates in plaques in fat-fed animals but nor-
malizes only slowly on a normal diet.5 The persistence 
of DNA damage can reflect both ongoing damage-in-
ducing stimuli, for example, through ROS, and defects 
in DNA repair. A number of inherited defects that im-
pair DNA repair are associated with human atheroscle-
rosis or can promote atherosclerosis in animal models 
(reviewed elsewhere7). In contrast, whether the far 
lower endogenous levels of 8oxoG found in atheroscle-
rosis affect plaque development is not known. A recent 
study has shown that knockout of the DNA glycosyl-
ase 8oxoG DNA glycosylase (OGG1) in macrophages 
promotes atherosclerosis and that OGG1 transcript 
expression was reduced in human plaques compared 
with normal vessels8; however, whether the observed 
decreased OGG1 expression translates into DNA repair 
defects is unknown.
We show that human atherosclerotic plaque VSMCs 
have defective 8oxoG BER, associated with decreased 
expression and acetylation of OGG1. We establish 
OGG1 as a major 8oxoG repair enzyme in VSMCs and 
that OGG1 activity in VSMCs is controlled by lysine 
338/341 acetylation. We identify p300 and sirtuin 1 
(SIRT1) as major acetyltransferase and deacetylase 
enzymes directly targeting OGG1 and thus regulat-
ing 8oxoG BER and 8oxoG content in VSMCs. p300 
expression is reduced in plaque VSMCs and by oxida-
tive stress, and reduced formation of the p300-OGG1 
complex compromises OGG1 activity and protein sta-
bility. Inhibiting endogenous oxidative damage by res-
cuing VSMC OGG1 markedly reduces atherosclerosis 
in vivo, an effect that requires OGG1 acetylation. Our 
findings indicate that human atherosclerosis is charac-
terized by defective 8oxoG BER and that endogenous 
levels of oxidative DNA damage in VSMCs promote 
atherosclerosis.
METHODS
The data that support the findings of this study are available 
within the article, in the Data Supplement, and from the cor-
responding author on reasonable request.
Human Atherosclerotic Plaque and 
Normal Vessels
Human tissue was obtained under informed consent with pro-
tocols approved by the Cambridge or Huntingdon Research 
Clinical Perspective
What Is New?
• We demonstrate that human atherosclerosis exhib-
its increased oxidative DNA damage and defective 
repair of that damage in vascular smooth muscle 
cells (VSMCs).
• Defective base excision repair is caused by reduced 
expression, acetylation, and activity of the enzyme 
8-oxoguanine DNA glycosylase in atherosclerosis.
• 8-Oxoguanine DNA glycosylase is a major base 
excision repair enzyme in VSMCs, the activity and 
protein stability of which are regulated by acetyla-
tion through the p300 acetyltransferase and sirtuin 
1 deacetylase enzymes.
• Correcting the base excision repair defect in VSMCs 
alone markedly reduces plaque formation, indicat-
ing that endogenous levels of oxidative DNA dam-
age in VSMCs promote plaque development.
What Are the Clinical Implications?
• Oxidative DNA damage accumulates slowly in ath-
erosclerosis and disappears only very slowly when 
hyperlipidemia is corrected.
• Oxidative DNA damage causes inflammation, cell 
death, and cell senescence, all of which promote 
atherogenesis.
• 8-Oxoguanine DNA glycosylase protects VSMCs 
against oxidative DNA damage, identifying base 
excision repair as a possible therapeutic target in 
atherosclerosis.
• Protection against oxidative DNA damage or 
increased DNA repair is beneficial over and above 
the standard clinical approach of reducing risk 
factors for coronary artery disease that promote 
damage, including hypercholesterolemia, diabetes 
mellitus, and smoking.
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Ethical Committee. Atherosclerotic plaques and normal aorta 
were obtained from separate patients undergoing carotid 
endarterectomy or aortic valve replacement, respectively.
Experimental Animals
All in vivo experiments followed UK Home Office licensing and 
were approved by the local animal ethics committee. Transgenic 
mice were generated as described in the online-only Data 
Supplement. The global OGG−/− and SM22α-SIRT1ex4/ex4 condi-
tional transgenic mouse models were generated as described 
previously.9,10 OGG1−/− mouse embryos were a gift from Christi 
Walter (University of Texas Health Science Center, Houston, TX).
Atherosclerosis Protocols
Male and female littermate control ApoE−/−, SM22α-OGG1/
ApoE−/−, and SM22α-OGG1K-R/ApoE−/− mice were fed high-fat 
Western diet (829-100, Special Diet Services, 21% total fat, 
0.2% cholesterol, 0% sodium cholate) from 8 to 22 weeks.
Histological Analysis and Oil Red O 
Staining of Descending Aorta
Atherosclerosis extent and composition were analyzed as 
described previously10 and in the online-only Data Supplement.
Cell Culture
Human, rat, and mouse VSMCs were cultured as described 
previously11 and in the online-only Data Supplement.
Transfections and Virus Infections
Transfections and retrovirus infections were performed as 
described previously10 and in the online-only Data Supplement.
CRISPR-Mediated Gene Silencing
Gene silencing experiments were performed as described in 
the online-only Data Supplement.
Real-Time Polymerase Chain Reaction
Oligonucleotide sequences used are listed in Table I in the 
online-only Data Supplement.
Oligonucleotide Incision Assay
8oxoG BER activity in nuclear lysates was determined as 
described previously12 and in the online-only Data Supplement.
8oxoG ELISA
8oxoG levels were assessed with an ELISA assay (Abcam) as 
described in the online-only Data Supplement.
Intracellular ROS Measurement
Intracellular ROS was measured as described previously13 and 
in the online-only Data Supplement.
Annexin V/PI Flow Cytometry
Cell death was determined with an apoptosis detection kit (BD 
BioSciences) as described in the online-only Data Supplement.
Comet Assay
Comet assay was performed with mouse VSMCs as described 
previously11 and in the online-only Data Supplement.
Immunofluorescence
Immunofluorescence analysis was performed as described 
previously14 and in the online-only Data Supplement.
Immunoprecipitation and Western 
blotting
Immunoprecipitation assays and Western blotting were per-
formed as described previously11 and in the online-only Data 
Supplement.
Chromatin Immunoprecipitation–
Quantitative Polymerase Chain Reaction 
Chromatin immunoprecipitation was performed as described 
in the online-only Data Supplement.
Statistical Analysis
Sample sizes were selected on the basis of previous experi-
ments that identified significant differences in plaque 
development in mice. No randomization was applied 
because all mice used were genetically defined, inbred 
mice. Blinding was used, and no animals were excluded 
from analysis. Data shown are mean±SEM. Normality of 
distribution was determined with D’Agostino-Pearson 
omnibus normality tests. Statistical significance was deter-
mined by 1-way ANOVA followed by Bonferroni posttest 
when >2 groups were compared and a 2-tailed Student t 
test to compare 1 groups of data using Prism 6.0 (Graph 
Pad). Differences were considered statistically significant at 
a value of P<0.05.
RESULTS
Human Atherosclerotic Plaque VSMCs 
Show Reduced BER Activity
Previous studies have shown that advanced human 
atherosclerotic plaques display increased 8oxoG le-
sions in cells expressing VSMC or macrophage mark-
ers compared with normal arteries.15 Studies also show 
that plaques have increased ROS content compared 
with normal vessels,16,17 so increased 8oxoG may be 
caused by increased oxidative stress within the plaque, 
defective BER, or both. We therefore examined 8oxoG 
repair in VSMCs cultured from human carotid plaques 
or normal aorta from patients matched for age and 
sex, with cultures matched for passage number. Cells 
were fractionated into nuclear and cytoplasmic com-
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partments to assay nuclear or mitochondrial BER, 
respectively (Figure I in the online-only Data Supple-
ment), and 8oxoG repair activity was examined with 
a fluorescently labeled 8oxoG-containing molecular 
beacon that can be incised and assayed in real time. 
Plaque VSMCs showed a marked reduction in nuclear 
8oxoG repair activity compared with aortic VSMCs, but 
cytoplasmic 8oxoG repair activity was similar in both 
cell types (Figure 1A).
Although 8oxoG repair is mediated by a number 
of enzymes, knockout studies suggest that OGG1 is 
a major, nonredundant enzyme responsible for repair-
ing 8oxoG from the bulk of the genome in many tis-
sues18 and that activation of alternative pathways can-
not compensate for OGG1 deficiency. OGG1 mRNA 
was increased in human plaque VSMCs 1.5-fold on 
quantitative polymerase chain reaction (Figure  1B), 
but plaque VSMCs showed reduced total OGG1 pro-
tein expression compared with aortic VSMCs and a 
marked reduction in acetyl-OGG1 (Ac-OGG1) expres-
sion (Figure 1C). To determine whether protein expres-
sion in vitro reflects expression in VSMCs in vivo, we 
examined 8oxoG, Ac-OGG1, and OGG1 expression in 
human coronary plaques from American Heart Asso-
ciation grade IV lesions compared with normal undis-
eased aorta, colabeled with α-smooth muscle actin to 
identify VSMCs. 8oxoG lesions were increased in hu-
man plaque VSMCs (Figure  1D). Consistent with the 
in vitro data, human plaque VSMCs showed a reduced 
percentage of VSMCs expressing total OGG1 and a 
markedly reduced percentage of VSMCs expressing 
Ac-OGG1 versus aortic VSMCs (Figure 1D), suggesting 
that increased oxidative damage in plaque VSMCs may 
be the result of decreased expression and acetylation 
of OGG1.
OGG1 is a Major BER Enzyme in VSMCs
To determine whether OGG1 is an important regulator 
of 8oxoG BER in VSMCs, we knocked down OGG1 in 
vitro using CRISPR/Cas9 to delete exon 1 or 7 in rat 
VSMCs. OGG1 expression was efficiently and stably re-
duced in OGG1Exon1KO or OGG1Exon7KO cells (Figure 2A), 
with no compensatory effect on expression of other 
BER enzymes such as NEIL1 and NTH (Figure IIa in the 
online-only Data Supplement). Oxidative DNA damage 
was stimulated by treatment with tert-butyl hydro-
peroxide (t-BHP) for 1 hour, which induces oxidative 
stress and 8oxoG in VSMCs.15 Cells were left to recover 
for 0 to 24 hours, and 8oxoG BER activity was exam-
ined. t-BHP transiently inhibited BER activity in con-
trol cells, which then normalized by 24 hours; OGG1 
knockdown reduced both basal and t-BHP–induced 
8oxoG BER activity, such that OGG1 was responsible 
for >95% of 8oxoG BER activity (Figure 2B). Consis-
tent with t-BHP–induced inhibition of BER, t-BHP also 
increased intracellular 8oxoG content in VSMCs (Fig-
ure 2C), albeit with recovery incomplete by 24 hours. 
OGG1Exon1KO and OGG1Exon7KO cells showed higher basal 
and t-BHP–induced intracellular 8oxoG, which was 
completely unchanged at 24 hours (Figure  2C), con-
firming that OGG1 is a major BER enzyme repairing 
8oxoG in VSMCs.
Repair of 8oxoG Requires OGG1 
Acetylation
To determine whether 8oxoG repair activity requires 
OGG1 acetylation in VSMCs, we stably expressed wild-
type human OGG1, OGG1K-R, or the empty vector in rat 
VSMCs by retrovirus-mediated gene transfer. OGG1K-R 
is an acetylation site mutant in which lysine 338 and 
341 (which are active in 8oxoG repair19) are replaced 
by arginines. Exogenous human OGG1 was expressed 
at comparable levels in OGG1 and OGG1K-R cells (Fig-
ure 2D), was localized to the nucleus (Figure IIb in the 
online-only Data Supplement), and did not suppress en-
dogenous rat OGG1 expression (Figure 2D). However, 
Ac-OGG1 expression was increased in OGG1 but not 
OGG1K-R VSMCs (Figure  2D). OGG1 but not OGG1K-R 
cells showed significantly increased 8oxoG BER after t-
BHP compared with control cells expressing the empty 
vector alone (Figure 2E). Control, OGG1, and OGG1K-R 
VSMCs showed similar intracellular baseline 8oxoG and 
similar 8oxoG levels after 1 hour of t-BHP treatment; 
however, OGG1 but not OGG1K-R VSMCs displayed 
more rapid removal of 8oxoG (Figure 2F). To exclude the 
possibility that expression of OGG1 altered ROS genera-
tion by t-BHP, we examined ROS levels at baseline and 
after t-BHP in the 3 cell lines; ROS levels were identical 
in control, OGG1, and OGG1K-R VSMCs both at baseline 
and after t-BHP (Figure IIc in the online-only Data Sup-
plement), indicating that OGG1 acetylation regulates ef-
ficiency of 8oxoG removal after oxidative stress without 
affecting ROS.
OGG1 Acetylation and Stability Are 
Regulated by p300
Although the acetyltransferase p300 can acetylate 
OGG1 in cancer cells,19 the major acetyltransferase 
and deacetylase enzymes of OGG1 in VSMCs are not 
known, nor is their expression in atherosclerosis. We ex-
amined p300 expression in cultured normal aortic and 
plaque VSMCs and whether VSMC OGG1 and 8oxoG 
repair activity was regulated by p300. Both p300 mRNA 
expression (Figure IIIa in the online-only Data Supple-
ment) and protein expression (Figure 3A) were reduced 
in plaque compared with aortic VSMCs, and the per-
cent of VSMCs expressing p300 was also reduced in 
plaque VSMCs in vivo (Figure IIIb in the online-only 
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Figure 1. Human plaque VSMCs show defective nuclear BER activity and reduced acetyl-OGG1 expression.  
A, Base excision repair (BER) assay measuring incision of a fluorescently labeled 8-oxoguanine (8oxoG.C) oligonucleotide in nuclear and cytoplasmic fractions of 
cultured plaque and normal aortic vascular smooth muscle cells (VSMCs). Representative gel (Left) and quantification (Right) are shown. Incision product is denoted 
by an arrow (n=4). B, Quantitative polymerase chain reaction analysis of 8oxoG DNA glycosylase I (OGG1) expression in cultured plaque and normal aortic VSMCs 
(n=4). C, Western blot of OGG1 and acetylated OGG1 (Ac-OGG1) in plaque and normal aortic VSMCs (n=4). D, Immunohistochemistry for 8oxoG, Ac-OGG1, or 
OGG1 (brown) in sections of human plaques and normal aorta (n=10). Sections are also costained for α-smooth muscle actin (SMA; blue). Insets show high-power 
views of outlined areas. Negative controls using isotype-matched antibodies and quantification are shown below. Scale bars, 25 µm. All graphical data are mean±SEM. 
*P<0.05, **P<0.01, Student t test.
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Data Supplement). To examine whether oxidative stress 
could be the underlying cause of reduced p300 levels in 
plaque VSMCs, we treated control VSMCs with t-BHP 
for 1 hour and examined OGG1, Ac-OGG1, and p300 
protein expression up to 24 hours of recovery. t-BHP 
reduced both Ac-OGG1 and p300 expression in paral-
lel, which did not normalize by 24 hours (Figure 3B and 
Figure IIIc in the online-only Data Supplement), sug-
gesting that ROS-induced reduction of OGG1 acetyla-
tion is caused by the ROS-induced decrease in p300 
expression. The reduced OGG1 acetylation and p300 
expression even at 24 hours after t-BHP treatment (Fig-
ure 3B) may explain the incomplete 8oxoG repair seen 
in control cells (Figure 2C).
To examine whether p300 interacts with OGG1 at 
endogenous levels of expression in VSMCs, human 
Figure 2. OGG1 is the major BER enzyme for 8oxoG, and its activity is regulated by acetylation.  
A, 8-Oxoguanine (8oxoG) DNA glycosylase I (OGG1) protein expression in control or OGG1 exon1 or exon7 CRISPR knockout rat vascular smooth muscle cell lines (n=4). 
B, Base excision repair (BER) assay analysis and (C) 8oxoG intracellular levels measured by ELISA in control (Ctrl), OGG1Exon1KO, or OGG1Exon7KO rat vascular smooth muscle 
cells (VSMCs) at untreated baseline (-) or after tert-butyl hydroperoxide (t-BHP) treatment for 1 hour (t=0) and after t-BHP removal (4-, 8-, 24-hour recovery; n=5). D, 
Western blot of OGG1, acetylated OGG1 (Ac-OGG1), or myc tag in rat VSMCs expressing the empty vector (Ctrl), human OGG1 (OGG1), or acetylation mutant OGG1 
(OGG1K-R). Immunoblotting for OGG1 shows a lower band for endogenous rat OGG1 and a higher band for exogenous human OGG1 (n=4). E, BER assay analysis 
and (F) 8oxoG intracellular levels measured by ELISA in Ctrl, OGG1, or OGG1K-R cells at untreated baseline (-) or after t-BHP treatment for 1 hour (t=0) and after t-BHP 
removal (4-, 8-, 24-hour recovery; n=4). All graphical data are mean±SEM. *P<0.05, **P<0.01, ***P<0.001, 1-way ANOVA (Bonferroni post hoc).
D
ow
nloaded from
 http://ahajournals.org by on October 5, 2018
Shah et al Defective BER Promotes Atherosclerosis
October 2, 2018 Circulation. 2018;138:1446–1462. DOI: 10.1161/CIRCULATIONAHA.117.0332491452
OR
IG
IN
AL
 R
ES
EA
RC
H 
AR
TI
CL
E
VSMC lysates were immunoprecipated with an anti-
p300 antibody and probed for OGG1. p300 associated 
with OGG1 at endogenous levels of expression, and 
p300 complex formation with OGG1 was reduced by 
t-BHP (Figure  3C). Proximity ligation assay confirmed 
the p300/OGG1 interaction in human VSMCs and lo-
calized it primarily to the nucleus (Figure 3D; negative 
controls shown in Figure IIId in the online-only Data 
Supplement). To determine whether p300 regulates 
OGG1 acetylation and BER, we examined Ac-OGG1 
expression and BER activity in OGG1 or OGG1K-R cells 
treated with 1 hour of t-BHP and 24-hour recovery with 
or without CTPB, a specific activator of p300 histone 
acetyltransferase activity.20,21 CTPB induced hyperacety-
lation of histone 4 as expected22 (Figure 3E). CTPB in-
duced acetylation of endogenous rat and exogenous 
Figure 3. p300 is downregulated in plaque VSMCs and regulates OGG1 acetylation and BER.  
A, Western blot of p300 expression in cultured human plaque or normal aortic vascular smooth muscle cells (VSMCs; n=4). B, Western blot of 8-oxoguanine 
(8oxoG) DNA glycosylase I (OGG1), acetylated (Ac-) OGG1, and p300 levels in human VSMCs after 1 hour of tert-butyl hydroperoxide (t-BHP) treatment and 0- to 
24-hour recovery (n=4). C, Immunoprecipitation (IP) of human vascular smooth muscle cell lysates with an anti-p300 antibody analyzed by immunoblotting (IB) 
with anti-OGG1 and anti-p300 antibodies (n=3). D, Proximity ligation assay of OGG1-p300 interaction with rabbit anti-OGG1 and mouse anti-p300 antibodies 
(n=3). Scale bar, 20µm. E, Western blot for Ac-OGG1 and Ac-histone 4 (H4) in VSMCs expressing OGG1 or OGG1K-R with or without CTPB treatment (10 μmol/L; 
n=3). F, Quantification of base excision repair (BER) assay in OGG1 or OGG1K-R VSMCs either untreated (-) or after 1 hour of t-BHP (0) or 6-hour recovery with/
without CTPB (n=3). Representative gel is shown in Figure IVa in the online-only Data Supplement. G, Western blot of OGG1 expression after cycloheximide (CHX) 
treatment (0–4 hours) in OGG1 or OGG1K-R VSMCs with/without the p300 activator CTPB (n=3). H, Western blot of OGG1 expression after CHX treatment (0–4 
hours) in control cells with/without CTPB with/without the proteasomal degradation inhibitor MG132 (10 μmol/L; n=3). Scale bars, 25 µm. All graphical data are 
mean±SEM. *P<0.05, Student t test.
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human OGG1 in OGG1 cells, but human OGG1 re-
mained unchanged in OGG1K-R cells (Figure 3E). CTPB 
also increased 8oxoG repair activity in OGG1 cells but 
not in OGG1K-R cells (Figure  3F and Figure IVa in the 
online-only Data Supplement), in line with the effects 
on OGG1 acetylation. Furthermore, the p300 inhibi-
tor C64623 inhibited BER in VSMCs (Figure IVb in the 
online-only Data Supplement).
Our finding that OGG1 mRNA is increased in hu-
man plaque VSMCs but expression of OGG1 and 
acetylated OGG1 protein are reduced suggests that 
both expression and activity of OGG1 are controlled 
by posttranslational mechanisms. We therefore exam-
ined the stability of OGG1 protein in cells treated with 
cycloheximide to prevent de novo protein synthesis. 
Cycloheximide reduced expression of endogenous 
rat OGG1 in control, OGG1, and OGG1K-R VSMCs 
to a similar extent; in contrast, the reduction in hu-
man OGG1 was slower in OGG1 cells compared with 
OGG1K-R VSMCs, suggesting that acetylation of OGG1 
promotes its stability (Figure IVc in the online-only 
Data Supplement). To determine whether p300 regu-
lates OGG1 stability, we repeated this experiment with 
and without the p300 activator CTPB. CTPB enhanced 
the stability of OGG1 in OGG1 cells but not in OG-
G1K-R cells (Figure 3G and Figure IVd in the online-only 
Data Supplement). We also tested whether p300 reg-
ulates OGG1 stability through its degradation. OGG1 
stability was reduced in the presence of the p300 in-
hibitor C646, but OGG1 expression was restored after 
additional administration of the proteasomal inhibitor 
MG132 (Figure  3H and Figure IVe in the online-on-
ly Data Supplement), indicating that p300 regulates 
OGG1 expression and proteasome-mediated degrada-
tion through its acetylation.
SIRT1 is an OGG1 Deacetylase in VSMCs
The deacetylase responsible for inhibiting OGG1 activ-
ity in VSMCs is unknown because, although OGG1 in-
teracts with class I histone deacetylases, previous stud-
ies showed that the activity was not affected by the 
SIRT1 inhibitor nicotinamide.19 We therefore examined 
whether VSMC OGG1 activity and BER activity were 
regulated by SIRT1.
To determine whether OGG1 interacts with and is 
deacetylated by SIRT1, we generated VSMCs that sta-
bly express wild-type human SIRT1 or the deacetylase-
deficient mutant SIRT1H365Y by retrovirus-mediated 
gene transfer.10 VSMCs expressing the empty vector 
(control), SIRT1, or SIRT1H-Y were treated with t-BHP 
and SIRT1, and Ac-OGG1 and OGG1 protein expres-
sion was examined. SIRT1 but not SIRT1H-Y reduced 
Ac-OGG1 and total OGG1 expression (Figure  4A), 
suggesting that OGG1 is a SIRT1 deacetylation sub-
strate. Indeed, SIRT1 coimmunoprecipitated with 
OGG1 both at endogenous levels and when overex-
pressed (Figure  4B), and proximity ligation assay in 
human VSMCs confirmed this protein interaction at 
endogenous levels (Figure  4C and Figure Va in the 
online-only Data Supplement). Consistent with SIRT1 
reducing OGG1 acetylation, SIRT1 but not SIRT1H-Y 
reduced 8oxoG repair activity (Figure 4D and Figure 
Vb in the online-only Data Supplement) and increased 
intracellular 8oxoG content (Figure 4E). SIRT1 but not 
SIRT1H-Y also reduced OGG1 stability (Figure 4F), con-
sistent with SIRT1 deacetylation of OGG1. Because 
SIRT1 is both regulated by redox-mediated mecha-
nisms and can inhibit ROS generation (reviewed previ-
ously24,25), the differences in 8oxoG levels after t-BHP 
could be caused by different levels of ROS induced in 
each cell type; however, ROS levels in control, SIRT1, 
or SIRT1H-Y cells after t-BHP were similar (Figure Vc in 
the online-only Data Supplement). Finally, we exam-
ined the expression of OGG1 and Ac-OGG1 in aortas 
from ApoE−/− mice that express a truncated inactive 
SIRT1 (SIRT1∆ex4/∆ex4) from the SMC-specific SM22α 
(transgelin [Tagln]) promoter.10 SIRT1 expression was 
detectable in <1% of VSMCs in SM22-SIRT1∆ex4/∆ex4 
ApoE−/− mice, confirming the efficacy of the recom-
bination. OGG1 expression was seen at similar lev-
els in SM22-SIRT1∆ex4/∆ex4 ApoE−/− and control mice; 
in contrast, Ac-OGG1 expression was increased in 
SM22-SIRT1∆ex4/∆ex4 ApoE−/− mice, consistent with 
SIRT1 deacetylation of OGG1 (Figure  4G). Together 
these data indicate that SIRT1 binds to and regulates 
OGG1deacetylation and stability and thus regulates 
oxidative damage in VSMCs.
VSMC OGG1 Reduces Oxidative Damage 
and Atherosclerosis In Vivo
Whole-body or bone marrow cell–restricted knock-
out of OGG1 results in increased atherosclerosis in 
low-density lipoprotein receptor–null mice.8 However, 
OGG1 knockout results in massive 8oxoG accumula-
tion, and the effects of endogenous levels of 8oxoG 
found in atherosclerosis and VSMC OGG1 are not 
known. We therefore generated mice expressing myc-
tagged human OGG1 or OGG1K-R from the minimal 
SM22α promoter (SM22α-OGG1 or SM22α-OGG1K-R 
mice). This promoter is expressed in VSMCs in large 
arteries only26 and has an additional deletion of the 
CARG motif to prevent promoter downregulation 
during VSMC phenotypic change in atherosclerosis.27 
SM22α-OGG1 and SM22α-OGG1K-R mice were com-
pared against control mice and OGG1−/− mice.9 Mouse 
OGG1 mRNA expression was markedly reduced in 
all tissues in OGG1−/− mice but was not affected by 
coexpression of human OGG1 in SM22α-OGG1 or 
SM22α-OGG1K-R mice (Figure VIa in the online-only 
Data Supplement). Previous studies have also shown 
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Figure 4. SIRT1 binds OGG1 and regulates deacetylation of OGG1 in vitro and in vivo.  
A, Western blot of total sirtuin 1 (SIRT1), acetylated (Ac-) 8-oxoguanine (8oxoG) DNA glycosylase I (OGG1), and OGG1 expression in rat vascular smooth 
muscle cells (VSMCs) expressing the empty vector (control [Ctrl]), human SIRT1 (SIRT1), or deacetylase defective mutant SIRTH364Y cells after 1 hour of tert-
butyl hydroperoxide (t-BHP) treatment and after 0- to 6-hour recovery (n=3). Immunoblotting for SIRT1 shows a lower band for endogenous rat SIRT1 and a 
higher band for exogenous human SIRT1. B, Immunoprecipitation (IP) of human vascular smooth muscle cell lysates with an anti-SIRT1 antibody analyzed by 
immunoblotting (IB) with anti-SIRT1 and anti-OGG1 antibodies (n=3). C, Proximity ligation assay of OGG1-SIRT1 interaction with rabbit anti-OGG1 and mouse 
anti-SIRT1 antibodies (n=3). D, Quantification of base excision repair assay in Ctrl, SIRT1, or SIRT1H-Y VSMCs either untreated (-) or after 1 hour of t-BHP (0) or 
0- to 24-hour recovery (n=3). Representative gel is shown in Figure Vb in the online-only Data Supplement. E, 8oxoG intracellular levels measured by ELISA in 
control, SIRT1, or SIRT1H-Y VSMCs after 1 hour of t-BHP treatment and after 0- to 24-hour recovery (n=3). F, Western blot of OGG1 expression after cyclohexi-
mide (CHX; 0–4 hours) treatment of control, SIRT1, or SIRT1H-Y VSMCs (n=3). G, Immunohistochemistry for SIRT1, OGG1, or Ac-OGG1 (brown) in aortas from 
control ApoE−/− or SIRT1−/−/ApoE−/− mice (n=10). Tissue sections were also costained for α-smooth muscle actin (SMA; blue). Negative control sections with 
isotype-matched antibodies are shown below. Scale bar, 25 µm. All graphical data are mean±SEM. *P<0.05, ***P<0.001, 1-way ANOVA (Bonferroni post hoc).
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that the full-length SM22α promoter is also expressed 
in myeloid cells28; in contrast, the minimal SM22α pro-
moter–driven human OGG1 transgene was expressed 
only in aortas of SM22α-OGG1 mice but not periph-
eral blood, bone marrow cells, or spleen (Figure VIb in 
the online-only Data Supplement).
OGG1 protein expression was markedly reduced 
in VSMCs cultured from OGG1−/− mice but increased 
in SM22α-OGG1 and SM22α-OGG1K-R mice to simi-
lar levels (Figure  5A). Ac-OGG1 expression was in-
creased in SM22α-OGG1 mouse VSMCs but not 
SM22α-OGG1K-R VSMCs, whereas myc tag expression 
was observed only in transgenic lines (Figure  5A). 
ELISA of cultured VSMCs from these mice showed in-
creased 8oxoG in OGG1−/− mice and reduced 8oxoG 
in SM22α-OGG1 but not SM22α-OGG1K-R mice 
(Figure  5B). 8oxoG repair activity was increased in 
SM22α-OGG1 VSMCs, reduced in OGG1−/− VSMCs, 
but unchanged in SM22α-OGG1K-R VSMCs compared 
with control cells (Figure  5C and Figure VIc in the 
online-only Data Supplement). Thus, OGG1−/− mice 
allow examination of the effect of supraphysiologi-
cal levels of 8oxoG in all tissues on atherosclerosis; 
SM22α-OGG1 mice allow determination of the effect 
of rescuing OGG1 activity and suppressing endog-
enous levels of 8oxoG in VSMCs only; and SM22α-
OGG1K-R mice provide the acetylation-mutant control 
for SM22α-OGG1 mice.
Control wild-type, OGG1−/−, SM22α-OGG1, and 
SM22α-OGG1K-R mice were crossed onto an ApoE−/− 
background, weaned at 6 weeks, and male and fe-
male littermates were fat fed from 8 to 22 weeks of 
age. Weight gain (Figure VIIa in the online-only Data 
Supplement); serum lipids (Figure VIIb in the online-
only Data Supplement); systolic, diastolic, and mean 
arterial pressures; and heart rates were similar across 
all groups before and after fat feeding (Figure VIIc 
in the online-only Data Supplement). Atherosclero-
sis was increased in the descending aorta and aortic 
root in OGG1−/− ApoE−/− mice compared with controls 
(Figure  6A and 6B) but markedly decreased in both 
vascular beds in SM22α-OGG1 ApoE−/− mice; this 
protective effect was lost in SM22α-OGG1K-R ApoE−/− 
mice. Both necrotic core and fibrous cap areas were 
reduced in SM22α-OGG1 ApoE−/− mice (Figure  6C) 
compared with controls, with no overall change in 
relative proportions of the necrotic core and fibrous 
cap to the plaque or to each other (Figure VIIIa in 
the online-only Data Supplement). Analyses of male 
and female mice were grouped together (Figure VIIIb 
in the online-only Data Supplement) because we 
found no significant differences between sexes for 
any parameters measured except for body weight 
(not shown). Aortic plaques in SM22α-OGG1 mice 
had reduced 8oxoG levels compared with SM22α-
OGG1K-R and control mice, correlating with reduced 
plaque area, and significantly fewer terminal UTP nick 
end-labeling–positive apoptotic cells compared with 
SM22α-OGG1K-R mice (Figure VIIIc in the online-only 
Data Supplement).
Oxidative DNA Damage Accumulates at 
Telomeres; Induces Strand Breaks, Cell 
Senescence, and Apoptosis; and Drives 
Inflammation
Although VSMC OGG1 protected against atherosclero-
sis, the underlying mechanisms, which may be multiple, 
are unclear. For example, defects in BER can cause DNA 
strand breaks, resulting in cell death. Indeed, OGG1−/− 
VSMCs showed increased DNA strand breaks after 
t-BHP treatment with a reduced rate of repair; DNA 
damage was lower in SM22α-OGG1 but not SM22α-
OGG1K-R VSMCs versus control cells (Figure 7A). 8oxoG 
accumulation at telomeres can result in cell senescence 
and subsequent inflammation. Indeed, chromatin 
immunoprecipitation–quantitative polymerase chain 
reaction showed that OGG1−/− VSMCs had increased 
8oxoG accumulation at telomeres, and this was re-
duced in SM22α-OGG1 but not SM22α-OGG1K-R cells 
(Figure 7B). The percent of cells expressing senescence-
associated β-galactosidase after t-BHP was increased in 
OGG1−/− VSMCs and reduced in SM22α-OGG1 but not 
SM22α-OGG1K-R cells (Figure 7C and Figure IX in the 
online-only Data Supplement). Finally, t-BHP–induced 
cell death was increased in OGG1−/− and reduced in 
SM22α-OGG1 but not SM22α-OGG1K-R cells (Fig-
ure 7D), indicating that OGG1 overexpression protects 
VSMCs against apoptosis, but this depends on OGG1 
acetylation.
Oxidized DNA can also activate the inflammasome, 
resulting in release of proinflammatory cytokines such 
as interleukin (IL)-1β.8 Using quantitative polymerase 
chain reaction, we profiled aortic arch tissue from 
ApoE−/− mice after high-fat diet feeding for levels of 
inflammatory cytokines and inflammasome compo-
nents. SM22α-OGG1 ApoE−/− aortic tissue contained 
significantly decreased levels of transcripts for cyto-
kines IL-1β, IL-6, C-C motif chemokine ligand/mono-
cyte chemotactic protein 1, and tumor necrosis factor-
α and inflammasome components NLRP1 and NLRP3 
(Figure 7E), indicative of a shift toward a more anti-
inflammatory phenotype, with an opposite profile 
seen in OGG1−/− ApoE−/− mice. Serum levels of IL-1β, 
IL-6, C-C motif chemokine ligand/monocyte chemo-
tactic protein 1, and tumor necrosis factor-α were also 
decreased in SM22α-OGG1 ApoE−/− mice after high-
fat diet feeding compared with controls (Figure Xa 
in the online-only Data Supplement). To identify the 
source of these cytokines, we cultured VSMCs from 
these mice and determined cytokine secretion after 
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t-BHP treatment for 24 hours. t-BHP did not increase 
levels of IL-1β, IL-6, monocyte chemotactic protein 
1,and tumor necrosis factor-α in conditioned media of 
SM22α-OGG1 ApoE−/− cells compared with SM22α-
OGG1K-R ApoE−/− and control ApoE−/− cells (Figure Xb 
in the online-only Data Supplement). The anti-inflam-
matory profile in vivo of OGG1 mice and in culture of 
OGG1 VSMCs suggests that 8oxoG in VSMCs may ex-
ert a direct proinflammatory effect on the vessel wall.
DISCUSSION
Advanced human atherosclerotic plaques demon-
strate extensive 8oxoG accumulation in multiple cell 
types,5,6 and polymorphisms in some BER enzymes are 
associated with myocardial infarction,29 suggesting 
that impaired BER might promote plaque develop-
ment or instability. Indeed, OGG1 knockout in hema-
topoietic cells promotes atherogenesis and enhanced 
inflammasome activation in macrophages.8 However, 
VSMCs are long-lived cells,30 and the effects of oxi-
dative DNA damage in VSMCs in atherosclerosis are 
not known. In particular, chronic oxidative stress can 
increase 8oxoG levels >250-fold without apparent 
severe consequences,31 and OGG1−/− mice are born 
and develop normally with a normal life span, de-
spite a 7-fold increase in 8oxoG in nuclear DNA and 
a >20-fold increase in mitochondrial DNA.9,32–34 More 
controversially, some studies suggest that 8oxoG may 
actually protect against inflammation-induced DNA 
damage.35–37
Our study reports a number of novel findings. In 
particular, we demonstrate the following: evidence of 
defective 8oxoG BER in human plaque VSMCs, not 
just increased damage or reduced expression of BER 
enzymes; that reducing physiological 8oxoG levels re-
duces atherosclerosis, in addition to the detrimental 
effects of artificially elevated 8oxoG; the importance 
of OGG1 acetylation to its function in vivo; that SIRT1 
regulates OGG1 acetylation in vivo; and that p300 reg-
ulates OGG1 stability, not just activity. Specifically, we 
find that OGG1 is a major BER enzyme in VSMCs, the 
activity and protein stability of which are regulated by 
acetylation. Nuclear 8oxoG repair is defective in human 
atherosclerotic plaque VSMCs, associated with reduced 
acetylation of OGG1, which results in proteasome-
mediated OGG1 degradation and reduced activity. Our 
findings identify that atherosclerosis is a disease char-
acterized by defective BER in VSMCs and that endog-
Figure 5. OGG1 regulates 8oxoG expression 
in VSMCs in vivo and BER.  
A, Western blot of 8-oxoguanine (8oxoG) DNA 
glycosylase I (OGG1), acetylated (Ac-) OGG1, 
and myc tag in vascular smooth muscle cells 
(VSMCs) cultured from wild-type (control), 
OGG1−/−, SM22α-OGG1, or SM22α-OGG1K-R 
mouse aortas (n=4). B, 8oxoG intracellular 
levels measured by ELISA in control, OGG1−/−, 
SM22α-OGG1, or SM22α-OGG1K-R VSMCs 
(n=4). C, Base excision repair (BER) assay quanti-
fication in control, OGG1−/−, SM22α-OGG1, or 
SM22α-OGG1K-R VSMCs treated with tert-butyl 
hydroperoxide (t-BHP) for 1 hour and recovered 
for up to 24 hours (n=4). All graphical data are 
mean±SEM. *P<0.05, 1-way ANOVA (Bonfer-
roni post hoc).
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enous levels of oxidative DNA damage in VSMCs pro-
mote plaque development.
Human atherosclerotic plaques show a variety of 
DNA damage, including single- and double-strand 
breaks, telomere shortening, oxidative DNA dam-
age, and mutations (reviewed by Uryga et al7). Plaque 
VSMCs also show differences in expression of mul-
tiple DNA damage repair proteins, indicative of ac-
tivation of a DNA damage repair response.11 Some 
human DNA damage syndromes are associated 
with premature atherosclerosis, and previous stud-
ies in mice have shown that knockout of some DNA 
Figure 6. Effects of 8-oxoguanine DNA glycosylase I (OGG1) on plaque development and morphology in vivo.  
A, Representative images and quantification of en face preparations of descending aortas from control ApoE−/− (n=12), OGG1−/− ApoE−/− (n=14), SM22α-OGG1 
ApoE−/− (n=12), and SM22α-OGG1K-R ApoE−/− (n=13) mice stained with Oil Red O. Scale bar, 2 mm. B, Hematoxylin-eosin (H&E) and Masson trichrome immuno-
histochemistry of control ApoE−/− (n=12), OGG1−/− ApoE−/− (n=14), SM22α-OGG1 ApoE−/− (n=12), and SM22α-OGG1K-R ApoE−/− (n=13) mouse aortic roots at 22 
weeks after fat feeding from 8 to 22 weeks. Quantification of percent plaque size, plaque area, core area, and cap area (micrometers squared). Scale bar, 200 µm. 
All graphical data are mean±SEM. **P<0.01, ***P<0.001, 1-way ANOVA (Bonferroni post hoc).
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repair enzymes can promote atherosclerosis or vas-
cular dysfunction,8,38 suggesting that DNA damage 
may promote atherosclerosis. Indeed, a recent study 
showed downregulation of OGG1 transcripts in hu-
man plaque tissue compared with normal vessels.8 In 
contrast, we found that OGG1 mRNA is increased in 
human plaque VSMCs, whereas total OGG1 protein 
expression is decreased compared with aortic VSMCs. 
This difference is likely the result of the analyses being 
performed in whole-plaque tissue,8 which contains a 
heterogeneous mixture of cells, versus VSMC cultures 
in this study. However, this is the first study to dem-
onstrate that human atherosclerosis exhibits a DNA 
repair defect in VSMCs; that the defect is caused by 
reduced expression, acetylation, and activity of a spe-
cific DNA repair protein; and that correction of that 
defect in VSMCs alone can markedly reduce plaque 
formation.
Figure 7. 8-Oxoguanine (8oxoG) DNA glycosylase I (OGG1) regulates DNA strand breaks, cell senescence, apoptosis, and inflammasome pathways.  
A, Comet assay with quantification for cultured vascular smooth muscle cells (VSMCs) from wild-type control, OGG1−/−, SM22α-OGG1, or SM22α-OGG1K-R mice 
treated with tert-butyl hydroperoxide (t-BHP) for 1 hour and recovered for 6 hours (n=3). Scale bar, 100 µm. UT indicates untreated. B, Chromatin immunoprecip-
itation–quantitative polymerase chain reaction using primers to a telomeric region on 8oxoG-bound chromatin from control, OGG1−/−, SM22α-OGG1, or SM22α-
OGG1K-R mouse VSMCs (n=3). Data are shown as fold-change over immunoglobulin G (IgG). C, Percent VSMCs expressing senescence-associated β-galactosidase 
activity (SaβG) from wild-type control, OGG1−/−, SM22α-OGG1, or SM22α-OGG1K-R mice (n=3). D, Apoptosis assayed by annexin V and propidium iodide staining 
of mouse cells with/without t-BHP treatment by flow cytometry (n=3). E, Relative expression of transcripts for inflammatory cytokines and inflammasome-associat-
ed components in aortic arch tissue from control ApoE−/−, OGG1−/− ApoE−/−, SM22α-OGG1 ApoE−/−, and SM22α-OGG1K-R ApoE−/− mice after fat feeding (n=4). All 
graphical data are mean±SEM. *P<0.05, **P<0.01, ***P<0.001, 1-way ANOVA (Bonferroni post hoc).
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VSMCs in the normal vessel wall are characterized 
by low rates of cell division, cell death, and cell se-
nescence and maintain a contractile phenotype that 
expresses low levels of inflammatory cytokines (re-
viewed by Garrido and Bennett39). In contrast, VSMCs 
in atherosclerotic plaques or cultured from plaques 
show higher rates of cell death and cell senescence, 
accompanied by secretion of a variety of proinflam-
matory cytokines, some of which may be the result 
of cell senescence.40,41 Cell death and cell senescence 
promote both plaque development and plaque pro-
gression in atherosclerosis.42,43 Oxidative DNA dam-
age may affect multiple processes within VSMCs, and 
we show that VSMCs lacking OGG1 show increased 
cell death, cell senescence, and expression of inflam-
masome components, all of which are proatherogenic 
and all of which can be inhibited by overexpression 
of OGG1 after oxidative stress. Loss of OGG1 also in-
creases oxidized mitochondrial DNA, inflammasome 
activation, and apoptosis in macrophages.8 How-
ever, the profound reduction in plaque formation in 
SM22α-OGG1 compared with control mice demon-
strates that endogenous levels of 8oxoG found in 
VSMCs in atherosclerosis promote plaque develop-
ment and emphasizes the importance of oxidative 
DNA damage–mediated activation of cell death and 
senescence in VSMCs and of VSMC-driven inflamma-
tion in atherogenesis.
Our data also demonstrate the complex effects of 
oxidative stress in DNA repair. Acetylation regulates 
multiple protein properties such as stability, local-
ization, function, and protein-protein interactions.44 
OGG1-mediated BER activity is regulated by acetyla-
tion of lysines K338/K341 (shown by Bhakat et al19 
and here). Previous work in mouse embryonic fibro-
blasts showed decreased OGG1K-R repair activity in 
vitro19 but not the total loss of activity we observe 
in VSMCs, implying that acetylation may be a more 
important modification for OGG1 activity in VSMCs 
compared with other cell types. We also show that 
p300 and SIRT1 are major acetyltransferase and 
deacetylase enzymes, respectively, for OGG1 acetyla-
tion, but the mechanisms of their effects and the ef-
fects of oxidative stress may differ between cells. For 
example, although p300 can interact with OGG1 in 
some cell types,19 oxidative stress enhances histone 
acetyltransferase activity of p300 in lung cells with no 
change in expression; in contrast, p300 protein ex-
pression was downregulated after oxidative stress in 
VSMCs. Consistent with previous studies,19 ROS also 
transiently decreased OGG1 activity directly, which 
may be caused by the reduced state of the redox-
sensitive residues that determine its glycosylase activ-
ity.45,46 Our findings emphasize the detrimental effect 
of chronic oxidative stress in atherosclerosis through 
a positive feedback loop to generate further oxida-
tive DNA damage. ROS induce oxidative DNA damage 
but also impair 8oxoG BER by downregulating OGG1 
directly and indirectly through inhibiting p300 expres-
sion and thus OGG1 acetylation and protein stability. 
This finding may explain the observation that oxida-
tive DNA damage persists much longer in atheroscle-
rosis than other forms of DNA damage, even when 
the proatherogenic stimulus is removed.5
Although the regulation of OGG1 activity by acety-
lation is known,19 the identity of the OGG1 deacety-
lase has not been proven. SIRT1 is a NAD+-dependent 
lysine deacetylase with roles including cell aging, ge-
nomic stability, and cell apoptosis,47 but it has been ex-
cluded previously because the SIRT1 inhibitor nicotin-
amide did not increase OGG1 acetylation in HCT116 
cells.19 However, an association of SIRT1 and OGG1 
was not tested directly, and we have found that SIRT1 
substrates are tissue specific.10 We identify that SIRT1 
is a major enzyme regulating OGG1 activity, and its 
activity depends on its ability to deacetylate OGG1. 
Thus, SIRT1 but not SIRT1HY reduces OGG1 acetyla-
tion, reduces 8oxoG repair, and promotes persistence 
of oxidative DNA damage. SIRT1 deletion in vivo also 
increases Ac-OGG1, indicating that SIRT1 can regulate 
OGG1 activity at endogenous levels. However, SIRT1 is 
downregulated in human atherosclerotic plaques and 
in plaque and senescent VSMCs compared with nor-
mal VSMCs in culture,10 suggesting that SIRT1 regula-
tion of OGG1 may be particularly relevant in normal 
arteries as a way of deactivating OGG1 when oxida-
tive DNA repair is complete, but it may be less im-
portant in atherosclerosis in which the reduced p300 
expression results in reduced acetylated OGG1. How-
ever, SIRT1 also activates other components of the BER 
pathway, including the enzymes thymine DNA gly-
cosylase, apurinic/apyrimidinic endonuclease 1, and 
poly(ADP-ribose) polymerase 1,48,49 which may partly 
explain the profound effect of VSMC SIRT1 knockout 
in atherosclerosis.10
Our findings are consistent with the following 
model (Figure 8). OGG1 is preferentially acetylated by 
p300 in acute oxidative stress conditions that require 
8oxoG repair activity, leading to efficient 8oxoG BER. 
Ac-OGG1 is deacetylated by SIRT1 when 8oxoG BER is 
complete. However, chronic oxidative stress in athero-
sclerosis results in downregulation of p300 and p300-
mediated acetylation of OGG1, which in turn reduces 
OGG1 protein stability and thus expression and over-
all 8oxoG repair activity. ROS may also reduce OGG1 
activity directly via effects on redox-sensitive residues 
and glycosylase activity.45,46 8oxoG accumulation in 
VSMCs results in DNA strand breaks, cell senescence, 
cell death, inflammasome activation, and increased se-
cretion of proinflammatory cytokines, all of which pro-
mote atherogenesis. Rescue of VSMC OGG1 prevents 
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8oxoG accumulation and these consequences, protect-
ing against atherosclerosis.
CONCLUSIONS
We have identified that 8oxoG repair is reduced in 
VSMCs in human atherosclerosis as a result of chronic 
oxidative stress–induced reduction in expression, sta-
bility, acetylation, and activity of OGG1. SIRT1 is also 
a major regulator of OGG1 acetylation, expression, 
and activity. OGG1 protects VSMCs against oxidative 
DNA damage, cell senescence, and apoptosis and re-
duces atherosclerosis formation, identifying BER as a 
possible therapeutic target in atherosclerosis.
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